Akorn Inc (AKRX)

33.18
NASDAQ : Health Care
Prev Close 33.18
Day Low/High 0.00 / 0.00
52 Wk Low/High 17.61 / 35.40
Avg Volume 3.76M
Exchange NASDAQ
Shares Outstanding 124.53M
Market Cap 4.12B
EPS 1.50
P/E Ratio 22.51
Div & Yield N.A. (N.A)

Latest News

European Stocks High on French Perfume and Trump Bump

European Stocks High on French Perfume and Trump Bump

M&A, French election relief and renewed talk of reforms to taxes and trade all helped to push European stocks higher Tuesday

AKORN, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Investigates Sale To Fresenius Kabi

AKORN, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Investigates Sale To Fresenius Kabi

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Akorn, Inc.

Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More

Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More

Here are Tuesday's top research calls, including downgrades for Amazon and C.R. Bard, and new coverage of CyrusOne and Dow Chemical.

Fresenius and Merck Stocks Top DAX on Biosimilars Deal

Fresenius and Merck Stocks Top DAX on Biosimilars Deal

Fresenius announced a deal to buy U.S. generic drugmaker Akorn Inc for $4.75 billion and the biosimilars unit of German peer Merck KGaA.

Fresenius Kabi To Acquire Akorn

Fresenius Kabi To Acquire Akorn

Fresenius Kabi has agreed to acquire Akorn (NASDAQ: AKRX), a U.S.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ADS, AKRX, CSS, DISCA, GPS, LOCO Downgrades: CVTI, NCR Initiations: FLOW Read on to get TheStreet Quant Ratings' detailed report:

Biotech Movers: OncoMed Tanks After Barrage of Bad News, Akorn Rises on Deal Talk

Biotech Movers: OncoMed Tanks After Barrage of Bad News, Akorn Rises on Deal Talk

OncoMed Pharmaceuticals, Geron and Akorn were among the biotech stock movers in premarket trading on Monday.

Bullish and Bearish Reversals in the Market

Bullish and Bearish Reversals in the Market

Finding the stocks that have changed direction.

2 Health-Care Stocks Ready to Break Out

2 Health-Care Stocks Ready to Break Out

Akorn and AmerisourceBergen are both flashing big moves, but in which direction is unclear.

Analysts' Actions -- FedEx, GoPro, Garmin, HP and More

Analysts' Actions -- FedEx, GoPro, Garmin, HP and More

Here are Monday's top research calls, including upgrades for FedEx, Garmin and HP, and a downgrade for GoPro.

7 Stocks Trending With Monster Volume

7 Stocks Trending With Monster Volume

Here's a technical look at how to play a number of stocks trending higher with strong volume.

Why Shares of Drug Maker Akorn Are a Buy After Losing 50% in 2016

Why Shares of Drug Maker Akorn Are a Buy After Losing 50% in 2016

Risk-tolerant investors should consider buying this stock on further dips.

Akorn Stock Sees Short Interest Move 15.3% Lower

Akorn Stock Sees Short Interest Move 15.3% Lower

The most recent short interest data has been released for the 11/15/2016 settlement date, which shows a 1,867,919 share decrease in total short interest for Akorn Inc , to 10,324,737, a decrease of 15.32% since 10/31/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CCJ, CMC, DF, DLNG, GATX, PCH, PFNX, PRAH, RDY, TMHC, VLO Downgrades: AKRX, BETR, EDGW, HLTH, KNDI, PRMW, SONC, VWR Initiations: RGNX Read on to get TheStreet Quant Ratings' detailed report:

Analysts' Actions -- Biogen, GoPro, L Brands, Time Warner and More

Analysts' Actions -- Biogen, GoPro, L Brands, Time Warner and More

Here are Monday's top research calls, including upgrades for Biogen and Time Warner, and downgrades for GoPro and L Brands.

TheStreet Quant Rating: B- (Buy)